Global Oral Diabetes Medicine Market Growth 2026-2032
The global Oral Diabetes Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oral Diabetes Medicine players cover Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oral Diabetes Medicine Industry Forecast” looks at past sales and reviews total world Oral Diabetes Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Diabetes Medicine sales for 2026 through 2032. With Oral Diabetes Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Diabetes Medicine industry.
This Insight Report provides a comprehensive analysis of the global Oral Diabetes Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Diabetes Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Diabetes Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Diabetes Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Diabetes Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Diabetes Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oral Diabetes Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oral Diabetes Medicine players cover Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oral Diabetes Medicine Industry Forecast” looks at past sales and reviews total world Oral Diabetes Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Diabetes Medicine sales for 2026 through 2032. With Oral Diabetes Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Diabetes Medicine industry.
This Insight Report provides a comprehensive analysis of the global Oral Diabetes Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Diabetes Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Diabetes Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Diabetes Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Diabetes Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Diabetes Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- DPP-4
- GLP-1
- SGLT-2
- Type 1 Diabetes
- Type 2 Diabetes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Biocon
- Boehringer Ingelheim
- Merck & Co.
- Johnson & Johnson
- Novartis
- Novo Nordisk
- Takeda
- AstraZeneca
- Huadong Medicine
- Eli Lilly and Company
- Deyuan Pharmaceutical
- Hengrui Medicine
- What is the 10-year outlook for the global Oral Diabetes Medicine market?
- What factors are driving Oral Diabetes Medicine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Oral Diabetes Medicine market opportunities vary by end market size?
- How does Oral Diabetes Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Diabetes Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral Diabetes Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral Diabetes Medicine by Country/Region, 2021, 2025 & 2032
2.2 Oral Diabetes Medicine Segment by Type
2.2.1 DPP-4
2.2.2 GLP-1
2.2.3 SGLT-2
2.2.4 Oral Diabetes Medicine Sales by Type
2.2.4.1 Global Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Oral Diabetes Medicine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Oral Diabetes Medicine Sale Price by Type (2021-2026)
2.3 Oral Diabetes Medicine Segment by Application
2.3.1 Type 1 Diabetes
2.3.2 Type 2 Diabetes
2.3.3 Oral Diabetes Medicine Sales by Application
2.3.3.1 Global Oral Diabetes Medicine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Oral Diabetes Medicine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Oral Diabetes Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral Diabetes Medicine Breakdown Data by Company
3.1.1 Global Oral Diabetes Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Oral Diabetes Medicine Sales Market Share by Company (2021-2026)
3.2 Global Oral Diabetes Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Oral Diabetes Medicine Revenue by Company (2021-2026)
3.2.2 Global Oral Diabetes Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Oral Diabetes Medicine Sale Price by Company
3.4 Key Manufacturers Oral Diabetes Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Diabetes Medicine Product Location Distribution
3.4.2 Players Oral Diabetes Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL DIABETES MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Oral Diabetes Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral Diabetes Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral Diabetes Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral Diabetes Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Oral Diabetes Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral Diabetes Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Diabetes Medicine Sales Growth
4.4 APAC Oral Diabetes Medicine Sales Growth
4.5 Europe Oral Diabetes Medicine Sales Growth
4.6 Middle East & Africa Oral Diabetes Medicine Sales Growth
5 AMERICAS
5.1 Americas Oral Diabetes Medicine Sales by Country
5.1.1 Americas Oral Diabetes Medicine Sales by Country (2021-2026)
5.1.2 Americas Oral Diabetes Medicine Revenue by Country (2021-2026)
5.2 Americas Oral Diabetes Medicine Sales by Type (2021-2026)
5.3 Americas Oral Diabetes Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Diabetes Medicine Sales by Region
6.1.1 APAC Oral Diabetes Medicine Sales by Region (2021-2026)
6.1.2 APAC Oral Diabetes Medicine Revenue by Region (2021-2026)
6.2 APAC Oral Diabetes Medicine Sales by Type (2021-2026)
6.3 APAC Oral Diabetes Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Diabetes Medicine by Country
7.1.1 Europe Oral Diabetes Medicine Sales by Country (2021-2026)
7.1.2 Europe Oral Diabetes Medicine Revenue by Country (2021-2026)
7.2 Europe Oral Diabetes Medicine Sales by Type (2021-2026)
7.3 Europe Oral Diabetes Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Diabetes Medicine by Country
8.1.1 Middle East & Africa Oral Diabetes Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral Diabetes Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral Diabetes Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Oral Diabetes Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Diabetes Medicine
10.3 Manufacturing Process Analysis of Oral Diabetes Medicine
10.4 Industry Chain Structure of Oral Diabetes Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Diabetes Medicine Distributors
11.3 Oral Diabetes Medicine Customer
12 WORLD FORECAST REVIEW FOR ORAL DIABETES MEDICINE BY GEOGRAPHIC REGION
12.1 Global Oral Diabetes Medicine Market Size Forecast by Region
12.1.1 Global Oral Diabetes Medicine Forecast by Region (2027-2032)
12.1.2 Global Oral Diabetes Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral Diabetes Medicine Forecast by Type (2027-2032)
12.7 Global Oral Diabetes Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Oral Diabetes Medicine Product Portfolios and Specifications
13.1.3 Sanofi Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Biocon
13.2.1 Biocon Company Information
13.2.2 Biocon Oral Diabetes Medicine Product Portfolios and Specifications
13.2.3 Biocon Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Biocon Main Business Overview
13.2.5 Biocon Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Oral Diabetes Medicine Product Portfolios and Specifications
13.4.3 Merck & Co. Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Oral Diabetes Medicine Product Portfolios and Specifications
13.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Oral Diabetes Medicine Product Portfolios and Specifications
13.6.3 Novartis Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Oral Diabetes Medicine Product Portfolios and Specifications
13.7.3 Novo Nordisk Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Oral Diabetes Medicine Product Portfolios and Specifications
13.8.3 Takeda Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Oral Diabetes Medicine Product Portfolios and Specifications
13.9.3 AstraZeneca Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Huadong Medicine
13.10.1 Huadong Medicine Company Information
13.10.2 Huadong Medicine Oral Diabetes Medicine Product Portfolios and Specifications
13.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huadong Medicine Main Business Overview
13.10.5 Huadong Medicine Latest Developments
13.11 Eli Lilly and Company
13.11.1 Eli Lilly and Company Company Information
13.11.2 Eli Lilly and Company Oral Diabetes Medicine Product Portfolios and Specifications
13.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly and Company Main Business Overview
13.11.5 Eli Lilly and Company Latest Developments
13.12 Deyuan Pharmaceutical
13.12.1 Deyuan Pharmaceutical Company Information
13.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolios and Specifications
13.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Deyuan Pharmaceutical Main Business Overview
13.12.5 Deyuan Pharmaceutical Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine Oral Diabetes Medicine Product Portfolios and Specifications
13.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Diabetes Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral Diabetes Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral Diabetes Medicine by Country/Region, 2021, 2025 & 2032
2.2 Oral Diabetes Medicine Segment by Type
2.2.1 DPP-4
2.2.2 GLP-1
2.2.3 SGLT-2
2.2.4 Oral Diabetes Medicine Sales by Type
2.2.4.1 Global Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Oral Diabetes Medicine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Oral Diabetes Medicine Sale Price by Type (2021-2026)
2.3 Oral Diabetes Medicine Segment by Application
2.3.1 Type 1 Diabetes
2.3.2 Type 2 Diabetes
2.3.3 Oral Diabetes Medicine Sales by Application
2.3.3.1 Global Oral Diabetes Medicine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Oral Diabetes Medicine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Oral Diabetes Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oral Diabetes Medicine Breakdown Data by Company
3.1.1 Global Oral Diabetes Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Oral Diabetes Medicine Sales Market Share by Company (2021-2026)
3.2 Global Oral Diabetes Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Oral Diabetes Medicine Revenue by Company (2021-2026)
3.2.2 Global Oral Diabetes Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Oral Diabetes Medicine Sale Price by Company
3.4 Key Manufacturers Oral Diabetes Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Diabetes Medicine Product Location Distribution
3.4.2 Players Oral Diabetes Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL DIABETES MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Oral Diabetes Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral Diabetes Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral Diabetes Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral Diabetes Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Oral Diabetes Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral Diabetes Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Diabetes Medicine Sales Growth
4.4 APAC Oral Diabetes Medicine Sales Growth
4.5 Europe Oral Diabetes Medicine Sales Growth
4.6 Middle East & Africa Oral Diabetes Medicine Sales Growth
5 AMERICAS
5.1 Americas Oral Diabetes Medicine Sales by Country
5.1.1 Americas Oral Diabetes Medicine Sales by Country (2021-2026)
5.1.2 Americas Oral Diabetes Medicine Revenue by Country (2021-2026)
5.2 Americas Oral Diabetes Medicine Sales by Type (2021-2026)
5.3 Americas Oral Diabetes Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Diabetes Medicine Sales by Region
6.1.1 APAC Oral Diabetes Medicine Sales by Region (2021-2026)
6.1.2 APAC Oral Diabetes Medicine Revenue by Region (2021-2026)
6.2 APAC Oral Diabetes Medicine Sales by Type (2021-2026)
6.3 APAC Oral Diabetes Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Diabetes Medicine by Country
7.1.1 Europe Oral Diabetes Medicine Sales by Country (2021-2026)
7.1.2 Europe Oral Diabetes Medicine Revenue by Country (2021-2026)
7.2 Europe Oral Diabetes Medicine Sales by Type (2021-2026)
7.3 Europe Oral Diabetes Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Diabetes Medicine by Country
8.1.1 Middle East & Africa Oral Diabetes Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral Diabetes Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral Diabetes Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Oral Diabetes Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Diabetes Medicine
10.3 Manufacturing Process Analysis of Oral Diabetes Medicine
10.4 Industry Chain Structure of Oral Diabetes Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Diabetes Medicine Distributors
11.3 Oral Diabetes Medicine Customer
12 WORLD FORECAST REVIEW FOR ORAL DIABETES MEDICINE BY GEOGRAPHIC REGION
12.1 Global Oral Diabetes Medicine Market Size Forecast by Region
12.1.1 Global Oral Diabetes Medicine Forecast by Region (2027-2032)
12.1.2 Global Oral Diabetes Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral Diabetes Medicine Forecast by Type (2027-2032)
12.7 Global Oral Diabetes Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Oral Diabetes Medicine Product Portfolios and Specifications
13.1.3 Sanofi Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Biocon
13.2.1 Biocon Company Information
13.2.2 Biocon Oral Diabetes Medicine Product Portfolios and Specifications
13.2.3 Biocon Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Biocon Main Business Overview
13.2.5 Biocon Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Oral Diabetes Medicine Product Portfolios and Specifications
13.4.3 Merck & Co. Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Oral Diabetes Medicine Product Portfolios and Specifications
13.5.3 Johnson & Johnson Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Oral Diabetes Medicine Product Portfolios and Specifications
13.6.3 Novartis Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Oral Diabetes Medicine Product Portfolios and Specifications
13.7.3 Novo Nordisk Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Oral Diabetes Medicine Product Portfolios and Specifications
13.8.3 Takeda Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Oral Diabetes Medicine Product Portfolios and Specifications
13.9.3 AstraZeneca Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Huadong Medicine
13.10.1 Huadong Medicine Company Information
13.10.2 Huadong Medicine Oral Diabetes Medicine Product Portfolios and Specifications
13.10.3 Huadong Medicine Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huadong Medicine Main Business Overview
13.10.5 Huadong Medicine Latest Developments
13.11 Eli Lilly and Company
13.11.1 Eli Lilly and Company Company Information
13.11.2 Eli Lilly and Company Oral Diabetes Medicine Product Portfolios and Specifications
13.11.3 Eli Lilly and Company Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Eli Lilly and Company Main Business Overview
13.11.5 Eli Lilly and Company Latest Developments
13.12 Deyuan Pharmaceutical
13.12.1 Deyuan Pharmaceutical Company Information
13.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolios and Specifications
13.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Deyuan Pharmaceutical Main Business Overview
13.12.5 Deyuan Pharmaceutical Latest Developments
13.13 Hengrui Medicine
13.13.1 Hengrui Medicine Company Information
13.13.2 Hengrui Medicine Oral Diabetes Medicine Product Portfolios and Specifications
13.13.3 Hengrui Medicine Oral Diabetes Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hengrui Medicine Main Business Overview
13.13.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Diabetes Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral Diabetes Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DPP-4
Table 4. Major Players of GLP-1
Table 5. Major Players of SGLT-2
Table 6. Global Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 7. Global Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Table 8. Global Oral Diabetes Medicine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Oral Diabetes Medicine Revenue Market Share by Type (2021-2026)
Table 10. Global Oral Diabetes Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Oral Diabetes Medicine Sale by Application (2021-2026) & (K Units)
Table 12. Global Oral Diabetes Medicine Sale Market Share by Application (2021-2026)
Table 13. Global Oral Diabetes Medicine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Oral Diabetes Medicine Revenue Market Share by Application (2021-2026)
Table 15. Global Oral Diabetes Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Oral Diabetes Medicine Sales by Company (2021-2026) & (K Units)
Table 17. Global Oral Diabetes Medicine Sales Market Share by Company (2021-2026)
Table 18. Global Oral Diabetes Medicine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Oral Diabetes Medicine Revenue Market Share by Company (2021-2026)
Table 20. Global Oral Diabetes Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Oral Diabetes Medicine Producing Area Distribution and Sales Area
Table 22. Players Oral Diabetes Medicine Products Offered
Table 23. Oral Diabetes Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Diabetes Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Oral Diabetes Medicine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Oral Diabetes Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Oral Diabetes Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Oral Diabetes Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Oral Diabetes Medicine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Oral Diabetes Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Oral Diabetes Medicine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Oral Diabetes Medicine Sales Market Share by Country (2021-2026)
Table 36. Americas Oral Diabetes Medicine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Oral Diabetes Medicine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Oral Diabetes Medicine Sales Market Share by Region (2021-2026)
Table 41. APAC Oral Diabetes Medicine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Oral Diabetes Medicine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Diabetes Medicine
Table 53. Key Market Challenges & Risks of Oral Diabetes Medicine
Table 54. Key Industry Trends of Oral Diabetes Medicine
Table 55. Oral Diabetes Medicine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Diabetes Medicine Distributors List
Table 58. Oral Diabetes Medicine Customer List
Table 59. Global Oral Diabetes Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Oral Diabetes Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Oral Diabetes Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Oral Diabetes Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Oral Diabetes Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Oral Diabetes Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Oral Diabetes Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Oral Diabetes Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Oral Diabetes Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Oral Diabetes Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Oral Diabetes Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Sanofi Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Oral Diabetes Medicine Product Portfolios and Specifications
Table 75. Sanofi Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Biocon Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 79. Biocon Oral Diabetes Medicine Product Portfolios and Specifications
Table 80. Biocon Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Biocon Main Business
Table 82. Biocon Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Oral Diabetes Medicine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Merck & Co. Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co. Oral Diabetes Medicine Product Portfolios and Specifications
Table 90. Merck & Co. Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck & Co. Main Business
Table 92. Merck & Co. Latest Developments
Table 93. Johnson & Johnson Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Oral Diabetes Medicine Product Portfolios and Specifications
Table 95. Johnson & Johnson Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Novartis Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Oral Diabetes Medicine Product Portfolios and Specifications
Table 100. Novartis Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Novo Nordisk Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 104. Novo Nordisk Oral Diabetes Medicine Product Portfolios and Specifications
Table 105. Novo Nordisk Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Latest Developments
Table 108. Takeda Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Oral Diabetes Medicine Product Portfolios and Specifications
Table 110. Takeda Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. AstraZeneca Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Oral Diabetes Medicine Product Portfolios and Specifications
Table 115. AstraZeneca Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Huadong Medicine Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 119. Huadong Medicine Oral Diabetes Medicine Product Portfolios and Specifications
Table 120. Huadong Medicine Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Huadong Medicine Main Business
Table 122. Huadong Medicine Latest Developments
Table 123. Eli Lilly and Company Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 124. Eli Lilly and Company Oral Diabetes Medicine Product Portfolios and Specifications
Table 125. Eli Lilly and Company Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Eli Lilly and Company Main Business
Table 127. Eli Lilly and Company Latest Developments
Table 128. Deyuan Pharmaceutical Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 129. Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolios and Specifications
Table 130. Deyuan Pharmaceutical Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Deyuan Pharmaceutical Main Business
Table 132. Deyuan Pharmaceutical Latest Developments
Table 133. Hengrui Medicine Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine Oral Diabetes Medicine Product Portfolios and Specifications
Table 135. Hengrui Medicine Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 1. Oral Diabetes Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral Diabetes Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DPP-4
Table 4. Major Players of GLP-1
Table 5. Major Players of SGLT-2
Table 6. Global Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 7. Global Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Table 8. Global Oral Diabetes Medicine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Oral Diabetes Medicine Revenue Market Share by Type (2021-2026)
Table 10. Global Oral Diabetes Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Oral Diabetes Medicine Sale by Application (2021-2026) & (K Units)
Table 12. Global Oral Diabetes Medicine Sale Market Share by Application (2021-2026)
Table 13. Global Oral Diabetes Medicine Revenue by Application (2021-2026) & ($ million)
Table 14. Global Oral Diabetes Medicine Revenue Market Share by Application (2021-2026)
Table 15. Global Oral Diabetes Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Oral Diabetes Medicine Sales by Company (2021-2026) & (K Units)
Table 17. Global Oral Diabetes Medicine Sales Market Share by Company (2021-2026)
Table 18. Global Oral Diabetes Medicine Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Oral Diabetes Medicine Revenue Market Share by Company (2021-2026)
Table 20. Global Oral Diabetes Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Oral Diabetes Medicine Producing Area Distribution and Sales Area
Table 22. Players Oral Diabetes Medicine Products Offered
Table 23. Oral Diabetes Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Diabetes Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Oral Diabetes Medicine Sales Market Share Geographic Region (2021-2026)
Table 28. Global Oral Diabetes Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Oral Diabetes Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Oral Diabetes Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Oral Diabetes Medicine Sales Market Share by Country/Region (2021-2026)
Table 32. Global Oral Diabetes Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Oral Diabetes Medicine Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 35. Americas Oral Diabetes Medicine Sales Market Share by Country (2021-2026)
Table 36. Americas Oral Diabetes Medicine Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 38. Americas Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 39. APAC Oral Diabetes Medicine Sales by Region (2021-2026) & (K Units)
Table 40. APAC Oral Diabetes Medicine Sales Market Share by Region (2021-2026)
Table 41. APAC Oral Diabetes Medicine Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 43. APAC Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 44. Europe Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 45. Europe Oral Diabetes Medicine Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 47. Europe Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral Diabetes Medicine Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Oral Diabetes Medicine Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Oral Diabetes Medicine Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Diabetes Medicine
Table 53. Key Market Challenges & Risks of Oral Diabetes Medicine
Table 54. Key Industry Trends of Oral Diabetes Medicine
Table 55. Oral Diabetes Medicine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Diabetes Medicine Distributors List
Table 58. Oral Diabetes Medicine Customer List
Table 59. Global Oral Diabetes Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Oral Diabetes Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Oral Diabetes Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Oral Diabetes Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Oral Diabetes Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Oral Diabetes Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Oral Diabetes Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Oral Diabetes Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Oral Diabetes Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Oral Diabetes Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Oral Diabetes Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Oral Diabetes Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Sanofi Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Oral Diabetes Medicine Product Portfolios and Specifications
Table 75. Sanofi Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Biocon Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 79. Biocon Oral Diabetes Medicine Product Portfolios and Specifications
Table 80. Biocon Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Biocon Main Business
Table 82. Biocon Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Oral Diabetes Medicine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Merck & Co. Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co. Oral Diabetes Medicine Product Portfolios and Specifications
Table 90. Merck & Co. Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck & Co. Main Business
Table 92. Merck & Co. Latest Developments
Table 93. Johnson & Johnson Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Oral Diabetes Medicine Product Portfolios and Specifications
Table 95. Johnson & Johnson Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Novartis Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Oral Diabetes Medicine Product Portfolios and Specifications
Table 100. Novartis Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Novo Nordisk Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 104. Novo Nordisk Oral Diabetes Medicine Product Portfolios and Specifications
Table 105. Novo Nordisk Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Latest Developments
Table 108. Takeda Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Oral Diabetes Medicine Product Portfolios and Specifications
Table 110. Takeda Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. AstraZeneca Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Oral Diabetes Medicine Product Portfolios and Specifications
Table 115. AstraZeneca Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Huadong Medicine Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 119. Huadong Medicine Oral Diabetes Medicine Product Portfolios and Specifications
Table 120. Huadong Medicine Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Huadong Medicine Main Business
Table 122. Huadong Medicine Latest Developments
Table 123. Eli Lilly and Company Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 124. Eli Lilly and Company Oral Diabetes Medicine Product Portfolios and Specifications
Table 125. Eli Lilly and Company Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Eli Lilly and Company Main Business
Table 127. Eli Lilly and Company Latest Developments
Table 128. Deyuan Pharmaceutical Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 129. Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolios and Specifications
Table 130. Deyuan Pharmaceutical Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Deyuan Pharmaceutical Main Business
Table 132. Deyuan Pharmaceutical Latest Developments
Table 133. Hengrui Medicine Basic Information, Oral Diabetes Medicine Manufacturing Base, Sales Area and Its Competitors
Table 134. Hengrui Medicine Oral Diabetes Medicine Product Portfolios and Specifications
Table 135. Hengrui Medicine Oral Diabetes Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Diabetes Medicine
Figure 2. Oral Diabetes Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Diabetes Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral Diabetes Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral Diabetes Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral Diabetes Medicine Sales Market Share by Country/Region (2025)
Figure 10. Oral Diabetes Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DPP-4
Figure 12. Product Picture of GLP-1
Figure 13. Product Picture of SGLT-2
Figure 14. Global Oral Diabetes Medicine Sales Market Share by Type in 2026
Figure 15. Global Oral Diabetes Medicine Revenue Market Share by Type (2021-2026)
Figure 16. Oral Diabetes Medicine Consumed in Type 1 Diabetes
Figure 17. Global Oral Diabetes Medicine Market: Type 1 Diabetes (2021-2026) & (K Units)
Figure 18. Oral Diabetes Medicine Consumed in Type 2 Diabetes
Figure 19. Global Oral Diabetes Medicine Market: Type 2 Diabetes (2021-2026) & (K Units)
Figure 20. Global Oral Diabetes Medicine Sale Market Share by Application (2025)
Figure 21. Global Oral Diabetes Medicine Revenue Market Share by Application in 2026
Figure 22. Oral Diabetes Medicine Sales by Company in 2026 (K Units)
Figure 23. Global Oral Diabetes Medicine Sales Market Share by Company in 2026
Figure 24. Oral Diabetes Medicine Revenue by Company in 2026 ($ millions)
Figure 25. Global Oral Diabetes Medicine Revenue Market Share by Company in 2026
Figure 26. Global Oral Diabetes Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Oral Diabetes Medicine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 29. Americas Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 30. APAC Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 31. APAC Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 32. Europe Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 33. Europe Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 36. Americas Oral Diabetes Medicine Sales Market Share by Country in 2026
Figure 37. Americas Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 39. Americas Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 40. United States Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Oral Diabetes Medicine Sales Market Share by Region in 2026
Figure 45. APAC Oral Diabetes Medicine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 47. APAC Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 48. China Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Oral Diabetes Medicine Sales Market Share by Country in 2026
Figure 56. Europe Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 58. Europe Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 59. Germany Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Diabetes Medicine in 2026
Figure 73. Manufacturing Process Analysis of Oral Diabetes Medicine
Figure 74. Industry Chain Structure of Oral Diabetes Medicine
Figure 75. Channels of Distribution
Figure 76. Global Oral Diabetes Medicine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Oral Diabetes Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Oral Diabetes Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral Diabetes Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Oral Diabetes Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Oral Diabetes Medicine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oral Diabetes Medicine
Figure 2. Oral Diabetes Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Diabetes Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Oral Diabetes Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oral Diabetes Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oral Diabetes Medicine Sales Market Share by Country/Region (2025)
Figure 10. Oral Diabetes Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DPP-4
Figure 12. Product Picture of GLP-1
Figure 13. Product Picture of SGLT-2
Figure 14. Global Oral Diabetes Medicine Sales Market Share by Type in 2026
Figure 15. Global Oral Diabetes Medicine Revenue Market Share by Type (2021-2026)
Figure 16. Oral Diabetes Medicine Consumed in Type 1 Diabetes
Figure 17. Global Oral Diabetes Medicine Market: Type 1 Diabetes (2021-2026) & (K Units)
Figure 18. Oral Diabetes Medicine Consumed in Type 2 Diabetes
Figure 19. Global Oral Diabetes Medicine Market: Type 2 Diabetes (2021-2026) & (K Units)
Figure 20. Global Oral Diabetes Medicine Sale Market Share by Application (2025)
Figure 21. Global Oral Diabetes Medicine Revenue Market Share by Application in 2026
Figure 22. Oral Diabetes Medicine Sales by Company in 2026 (K Units)
Figure 23. Global Oral Diabetes Medicine Sales Market Share by Company in 2026
Figure 24. Oral Diabetes Medicine Revenue by Company in 2026 ($ millions)
Figure 25. Global Oral Diabetes Medicine Revenue Market Share by Company in 2026
Figure 26. Global Oral Diabetes Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Oral Diabetes Medicine Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 29. Americas Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 30. APAC Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 31. APAC Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 32. Europe Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 33. Europe Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Oral Diabetes Medicine Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Oral Diabetes Medicine Revenue 2021-2026 ($ millions)
Figure 36. Americas Oral Diabetes Medicine Sales Market Share by Country in 2026
Figure 37. Americas Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Figure 38. Americas Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 39. Americas Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 40. United States Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Oral Diabetes Medicine Sales Market Share by Region in 2026
Figure 45. APAC Oral Diabetes Medicine Revenue Market Share by Region (2021-2026)
Figure 46. APAC Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 47. APAC Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 48. China Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. India Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Oral Diabetes Medicine Sales Market Share by Country in 2026
Figure 56. Europe Oral Diabetes Medicine Revenue Market Share by Country (2021-2026)
Figure 57. Europe Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 58. Europe Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 59. Germany Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 60. France Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Oral Diabetes Medicine Sales Market Share by Application (2021-2026)
Figure 67. Egypt Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Oral Diabetes Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Diabetes Medicine in 2026
Figure 73. Manufacturing Process Analysis of Oral Diabetes Medicine
Figure 74. Industry Chain Structure of Oral Diabetes Medicine
Figure 75. Channels of Distribution
Figure 76. Global Oral Diabetes Medicine Sales Market Forecast by Region (2027-2032)
Figure 77. Global Oral Diabetes Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Oral Diabetes Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral Diabetes Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Oral Diabetes Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Oral Diabetes Medicine Revenue Market Share Forecast by Application (2027-2032)
